A 12-year-old child with HIV is managed on a regimen that includes the pharmacokinetic booster ritonavir. He develops new-onset wheezing and is diagnosed with asthma. His primary care provider is considering prescribing an inhaled corticosteroid. Co-administration of ritonavir with which of the following common asthma medications requires extreme caution due to a significant drug-drug interaction?